Hold Indoco Remedies; target of Rs 243: Prabhudas Lilladher
Prabhudas Lilladher recommended Hold rating on Indoco Remedies with a target price of Rs 243 in its research report dated August 12, 2020.12-08-2020
12-08-2020
Earnings Call Transcript - Q1FY21 for Indoco Remedies
This earnings call has been removed at the company's request.11-08-2020
INDOCO REMEDIES LTD. - 532612 - Unaudited Results For The First Quarter Ended 30.06.2020
Submission of Standalone & Consolidated Unaudited Financial Results for the 1st qtr ended 30.06.202011-08-2020
Indoco gets USFDA nod for schizophrenia, bipolar disorder treatment drug
The approved product is therapeutically equivalent to the reference listed drug 'Zyprexa' of Eli Lilly06-08-2020
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco receives USFDA approval for Olanzapine Tablets06-08-2020
INDOCO REMEDIES LTD. - 532612 - Intimation Of AGM & Book Closure Date
Annual General Meeting & Book Closure Date03-08-2020
INDOCO REMEDIES LTD. - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Addendum to annual secretarial Compliance Report for the year ended 31.03.202029-07-2020
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Demise
Intimation of death of Dr. Anil M Naik- Non Executive Independent Director29-07-2020
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Board Meeting Notice13-07-2020